Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Immunotherapy|June 13, 2015
Adoptive T-cell therapy: a need for standard immune monitoringYarne Klaver, Andre Kunert, Stefan Sleijfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
T-cell Receptors for Clinical Therapy: <i>In Vitro</i> Assessment of Toxicity RiskAndre Kunert, Matthias Obenaus, Cor H J Lamers, et al.
Journal of Immunological Methods|September 16, 2003
Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFATNiels Schaft, Birgit Lankiewicz, Jan Willem Gratama, et al.
Biochemical Society Transactions|June 11, 2016
Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overviewCor H J Lamers, Yarne Klaver, Jan W Gratama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine productionRalph A Willemsen, Cees Ronteltap, Patrick Chames, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
CD8 alpha coreceptor to improve TCR gene transfer to treat melanoma: down-regulation of tumor-specific production of IL-4, IL-5, and IL-10Ralph A Willemsen, Zsolt Sebestyén, Cees Ronteltap, et al.
European Journal of Immunology|October 12, 2013
TCR-engineered T cells: a model of inducible TCR expression to dissect the interrelationship between two TCRsSimone Reuß, Zsolt Sebestyén, Niels Heinz, et al.
Cancers|April 3, 2020
Immunotherapy in Glioblastoma: Current Shortcomings and Future PerspectivesBas Weenink, Pim J French, Peter A E Sillevis Smitt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2018
Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?Marie Colombe Agahozo, Dora Hammerl, Reno Debets, et al.
Frontiers in Immunology|November 23, 2013
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuAndre Kunert, Trudy Straetemans, Coen Govers, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Immunotherapy|June 13, 2015
Adoptive T-cell therapy: a need for standard immune monitoringYarne Klaver, Andre Kunert, Stefan Sleijfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
T-cell Receptors for Clinical Therapy: <i>In Vitro</i> Assessment of Toxicity RiskAndre Kunert, Matthias Obenaus, Cor H J Lamers, et al.
Journal of Immunological Methods|September 16, 2003
Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFATNiels Schaft, Birgit Lankiewicz, Jan Willem Gratama, et al.
Biochemical Society Transactions|June 11, 2016
Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overviewCor H J Lamers, Yarne Klaver, Jan W Gratama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine productionRalph A Willemsen, Cees Ronteltap, Patrick Chames, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
CD8 alpha coreceptor to improve TCR gene transfer to treat melanoma: down-regulation of tumor-specific production of IL-4, IL-5, and IL-10Ralph A Willemsen, Zsolt Sebestyén, Cees Ronteltap, et al.
European Journal of Immunology|October 12, 2013
TCR-engineered T cells: a model of inducible TCR expression to dissect the interrelationship between two TCRsSimone Reuß, Zsolt Sebestyén, Niels Heinz, et al.
Cancers|April 3, 2020
Immunotherapy in Glioblastoma: Current Shortcomings and Future PerspectivesBas Weenink, Pim J French, Peter A E Sillevis Smitt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2018
Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?Marie Colombe Agahozo, Dora Hammerl, Reno Debets, et al.
Frontiers in Immunology|November 23, 2013
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuAndre Kunert, Trudy Straetemans, Coen Govers, et al.
Pageof 14